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Background
Gastric cancer is the fourth most common cancer and the
second leading cause of cancer-related deaths worldwide.
Galectins form a family of b-galactosides binding proteins
that recognize a variety of glycan-containing proteins at
the cell surface and are overexpressed in various tumors,
including gastric cancer. Galectins overexpression as well
as changes in their subcellular distribution has been asso-
ciated with gastric cancer progression and poor prognosis.
It is not well understood, however, how the interaction
between galectins and glycosylated receptors modulates
tumor development and growth. Since Notch receptors
and ligands contain glycan structures known to bind
galectins, we aim to demonstrate that galectins expression
in the tumor microenvironment may interfere with Notch
signaling activation during tumor development and
progression.
Materials and methods
Immunoprecipitation procedures with gastric cancer cell
line AGS (ATCC CRL-1739) and MKN45 (ACC 409)
were used to test for association between galectin-1/-3
and Notch-1 receptor. Furthermore, we transfected AGS
cell line with siRNA against galectin-1/-3 or scramble
using standard protocols (IDT DNA technologies), stimu-
late them with immobilized human recombinant delta-4
or Jagged-1 and assessed Notch-1 receptor activation.
Results
Galectin-1 and -3 interact with Notch-1 receptor and
differentially modulate Notch signaling pathway upon
activation by Delta/Jagged ligands. Galectin-1 knock-
down alters Notch-1 activation induced by Delta-4
whereas galectin-3 knockdown alters jagged-1-mediated
Notch-1 activation. Furthermore, we found that exogen-
ously added galectin-3 can enhance Notch-1 activation
by Jagged-1.
Conclusion
Our results suggest that galectin-1 and -3 interact with
Notch-1 receptor and differentially modulate Notch sig-
naling activation induced by Jagged-1 and Delta-4.
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